Can a cancer drug be tailored for japanese patients? a new trial seeks answers
Knowledge-focused
Not yet recruiting
This early-stage study is testing how a single dose of the experimental cancer drug adagrasib is processed by the body in 10 healthy adults of Japanese descent. Researchers will measure drug levels in the blood and monitor for any side effects. The goal is to gather safety and ph…
Phase: PHASE1 • Sponsor: Mirati Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC